(Q39763097)

14 September 2017

title

Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics (English)

1 reference

14 September 2017

Britta Haenisch

1

1 reference

14 September 2017

Heinz Bönisch

series ordinal

2

1 reference

14 September 2017

publication date

10 December 2009

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

381

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

33-39

1 reference

Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes

14 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-009-0479-8

Expression and immunolocalization of the plasma membrane monoamine transporter in the brain

21 January 2018

1 reference

12 December 2020

Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain

1 reference

12 December 2020

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

1 reference

12 December 2020

3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine.

1 reference

12 December 2020

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

1 reference

12 December 2020

The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia.

1 reference

12 December 2020

The norepinephrine transporter in physiology and disease.

1 reference

12 December 2020

The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model

1 reference

12 December 2020

Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.

1 reference

12 December 2020

Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus

1 reference

12 December 2020

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

1 reference

12 December 2020

Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Determination of selected phenothiazines in human plasma by solid-phase extraction and liquid chromatography with coulometric detection

1 reference

12 December 2020

Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells

1 reference

12 December 2020

The localisation of the extraneuronal monoamine transporter (EMT) in rat brain

1 reference

12 December 2020

Identification and characterization of a novel monoamine transporter in the human brain

1 reference

12 December 2020

Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy

1 reference

12 December 2020

Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain

1 reference

12 December 2020

Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3

1 reference

12 December 2020

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

12 December 2020

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

1 reference

12 December 2020

Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter

1 reference

12 December 2020

Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.

1 reference

12 December 2020

Interaction of organic cations with a newly identified plasma membrane monoamine transporter

1 reference

12 December 2020

The uptake and O-methylation of 3H-(�)-isoprenaline in rat cerebral cortex slices

1 reference

12 December 2020

Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain

1 reference

12 December 2020

Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors

1 reference

12 December 2020

Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Drug excretion mediated by a new prototype of polyspecific transporter

1 reference

12 December 2020

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

1 reference

12 December 2020

Development of a population pharmacokinetic database for tianeptine

1 reference

12 December 2020

The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart

1 reference

12 December 2020

Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference

1 reference

12 December 2020

10.1007/S00210-009-0479-8

Identifiers

DOI

1 reference

14 September 2017

1 reference